Motzer, R J <br/><br/>
Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  May 1998 
 - 1183-91 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Carcinoma, Renal Cell--drug therapy<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Interleukin-12--administration & dosage<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Recombinant Proteins--administration & dosage<br/>Treatment Outcome